Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T van Oosterom

Showing results (131-140 of 196) with videos related to

Pageof 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma GroupJ M Buesa, H T Mouridsen, A T van Oosterom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma IntergroupV H Bramwell, M Burgers, R Sneath, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumoursF A L M Eskens, H Dumez, R Hoekstra, et al.
British Journal of Cancer|February 1, 1995
Microvessel quantification in primary colorectal carcinoma: an immunohistochemical studyP B Vermeulen, D Verhoeven, H Fierens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomasP B Vermeulen, D Verhoeven, G Hubens, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma GroupH T Mouridsen, L Bastholt, R Somers, et al.
Seminars in Oncology|April 16, 1998
Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I studyL C Pronk, D Schrijvers, J H Schellens, et al.
British Journal of Cancer|May 20, 2004
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumoursF M Wachters, H J M Groen, J G Maring, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 1, 1985
Magnetic resonance imaging of primary malignant bone tumorsJ L Bloem, T H Falke, A H Taminiau, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervixJ. B. Vermorken, C. Mangioni, S. Pecorelli, et al.
Pageof 20

Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma GroupJ M Buesa, H T Mouridsen, A T van Oosterom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma IntergroupV H Bramwell, M Burgers, R Sneath, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumoursF A L M Eskens, H Dumez, R Hoekstra, et al.
British Journal of Cancer|February 1, 1995
Microvessel quantification in primary colorectal carcinoma: an immunohistochemical studyP B Vermeulen, D Verhoeven, H Fierens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomasP B Vermeulen, D Verhoeven, G Hubens, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma GroupH T Mouridsen, L Bastholt, R Somers, et al.
Seminars in Oncology|April 16, 1998
Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I studyL C Pronk, D Schrijvers, J H Schellens, et al.
British Journal of Cancer|May 20, 2004
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumoursF M Wachters, H J M Groen, J G Maring, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 1, 1985
Magnetic resonance imaging of primary malignant bone tumorsJ L Bloem, T H Falke, A H Taminiau, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervixJ. B. Vermorken, C. Mangioni, S. Pecorelli, et al.
Pageof 20